INSPERITY, INC. financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data INSPERITY, INC. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	2,941	3,300	3,829	4,315	4,287	4,973	5,939	6,486	6,581	6,812
Gross profit	492	573	682	733	807	820	1,011	1,037	1,052	900
General and administrative	86.7	101	111	123	113	124	156	177	224	203
Operating expenses	385	443	503	546	612	647	761	818	935	910
Operating income	106	130	179	187	195	173	250	219	117	-10
Interest expense	2.4	3.21	4.67	7.65	8.02	7.46	14	27	28	24
Interest income	1.27	3.41	7.99	10.7	2.6	2.45	9	33	37	30
Pre-tax income	105	130	182	190	189	168	245	225	126	-4
Income tax	39.2	45.7	46.9	38.5	51	44.2	66	54	35	3
Net income	66	84.4	135	151	138	124	179	171	91	-7
EBITDA	123	148	202	215	226	212	291	262	161	35
EPS, basic	1.55	2.02	3.24	3.72	3.57	3.22	4.70	4.53	2.44	-0.19
EPS, diluted	1.54	2.01	3.22	3.70	3.54	3.18	4.64	4.47	2.42	-0.19
Shares, basic (weighted)	41.7	41.1	41.2	40.2	38.5	38.4	38	38	38	38
Shares, diluted (weighted)	41.7	41.1	41.2	40.2	38.5	38.9	39	38	38	38

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	286	354	327	367	555	576	733	693	1,039	642
Short-term investments	1.85	24.6	77.5	47.9	82.5	121	90	135	133	40
Receivables	13.1	12.3	10	12.7	6.56	10.5	13.9	16	9	6
Other current assets	19.5	27	27.7	43.5	39.5	53.3	61.7	128	107	119
Total current assets	640	779	867	975	1,077	1,245	1,512	1,595	2,085	1,722
Property, plant and equipment	80.3	95.7	117	148	216	211	200	197	192	177
Lease right-of-use assets			0	56.9	60.7	62.8	56.5	57	65	63
Goodwill	12.7	12.7	12.7	12.7	12.7	12.7
Other non-current assets	1.84	3.54	4.85	5.98	4.55	15.2	29.4	23	13	41
Total assets	907	1,064	1,192	1,395	1,584	1,753	2,039	2,120	2,597	2,203
Accounts payable	4.19	6.45	10.6	4.57	6.2	6.41	7.73	11	10	6
Accrued liabilities	22.4	26	28.9	58.7	60.8	69.3	80.1	130	117	114
Total current liabilities	601	725	772	869	905	1,129	1,353	1,436	1,930	1,620
Long-term debt	104	104	144	269	369	369	369	369	369	369
Lease liabilities			0	58.9	64.3	64.2	55.6	58	66	66
Other non-current liabilities		1.75	10	0	6.29	0
Total liabilities	847	997	1,114	1,391	1,540	1,755	1,958	2,026	2,500	2,157
Total debt	104	104	144	269	369	369	369	369	369	369
Paid-in capital	8.96	25.3	36.8	48.1	95.5	109	151	185	222	257
Retained earnings	278	297	398	499	575	554	655	739	738	638
Treasury stock	-227	-256	-358	-544	-627	-665	-726	-831	-864	-850
Other comprehensive income	-0	-0.01	-0.01	0.01	0.01	-0.01	-0.08	0.01
Shareholders' equity	60.5	66.3	77.7	4.08	44.1	-2	81	94	97	46
Total equity	60.5	66.3	77.7	4.08	44.1	-2	81	94	97	46
Total liabilities and equity	907	1,064	1,192	1,395	1,584	1,753	2,039	2,120	2,597	2,203
Shares outstanding						38.3	37.9	37.3	37.2	37.7

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	66	84.4	135	151	138	124	179	171	91	-7
Depreciation and amortization	16.6	18.2	22.8	28.7	31.2	38.5	41	43	44	45
Stock-based compensation	16.6	24.3	20.4	24	60.1	40.6	50	53	61	61
Deferred income tax	2.95	9.74	-4.53	4.86	-5.65	4.71	-11	-4	-14	12
Change in receivables	-69.6	-63.7	-66.6	-65.2	73	-121	-110	-71	-135	3
Cash from operations	145	213	184	205	346	260	347	198	520	-278
Capital expenditures	-34	-33.3	-35.3	-56.3	-98.1	-32.9	-30	-40	-38	-31
Purchases of investments	-1.05	-1.75	-87.9	-110	-50.6	-58.2	-47	-48	-23	-26
Sales and maturities of investments	1.72	1.56	12.6	108	49.6	60	45	38	23	18
Cash from investing	-26	-33.3	-94.1	-29.7	-98.6	-31	-32	-22	-38	-31
Stock issued	0.6	0	0
Share buybacks	-144	0	0			-69.7	-73	-131	-63	-19
Dividends paid	-20.6	-65.8	-33.4	-48.6	-61.9	-144	-77	-84	-89	-90
Cash from financing	-90.2	-103	-104	-118	-53.6	-208	-141	-155	-173	-90
Net change in cash	16.5	68.2	-14.1	57.1	194	21.1	174	21	309	-399
Free cash flow	111	180	149	149	248	227	317	158	482	-309
Interest paid	2.4	3.26	4.01	7.42	8.98	7.27	13	22	32	23
Income taxes paid	44.1	40.9	40.7	38.3	51.1	53.8	57	63	33

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $47.83 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	12.9%	Gross profit / revenue.
Operating margin	-0.0%	Operating income / revenue.
EBITDA margin	0.6%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	-0.0%	Pre-tax income / revenue.
Net margin	-0.2%	Net income / revenue.
FCF margin	2.8%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	3.3%	Cash from operations / revenue.
Return on equity (ROE)	-26.2%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	-0.7%	Net income / average total assets.
Stock-based pay / revenue	0.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	0.5%	Capital expenditures / revenue.
D&A / revenue	0.6%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	3.5%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	4.7%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	9.7%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-14.4%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-3.8%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	2.2%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-108.5%	Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y	-78.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-50.6%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-31.1%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-107.7%	Net income vs the same period a year earlier. Only from a positive base.
EPS growth, 1y	-107.9%	EPS vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y	-153.5%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow growth, 1y	-164.1%	Free cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y	-52.6%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	-17.2%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	0.8%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	-15.2%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	2.6%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	6.8%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.0%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-0.9%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	-0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	1.11x	Current assets / current liabilities.
Quick ratio	0.41x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.41x	(Cash + short-term investments) / current liabilities.
Debt / equity	6.87x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	18.8%	Total debt / total assets.
Liabilities / assets	97.3%	Total liabilities / total assets.
Net debt	-$236.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	-5.76x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	-0.13x	Operating income / interest expense.
Working capital	$180.0M	Current assets - current liabilities.
Tangible book value	$61.0M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	3.08x	Revenue / average total assets.
Fixed asset turnover	40.4x	Revenue / average property, plant and equipment.
Capex / operating cash flow	13.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	-$0.41	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$176.21	Revenue / diluted weighted shares.
FCF per share	$4.97	Free cash flow / diluted weighted shares.
Operating cash flow per share	$5.77	Cash from operations / diluted weighted shares.
Book value per share	$1.56	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$1.56	Tangible book value / shares outstanding.
Cash per share	$16.79	(Cash + short-term investments) / shares outstanding.
Dividends / FCF	46.9%	Dividends paid / free cash flow, when free cash flow is positive.
Buybacks / FCF	2.1%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.83B	Share price x shares outstanding.
Enterprise value	$1.59B	Market cap + total debt - cash - short-term investments.
P/S	0.27x	Market cap / revenue.
P/B	29.9x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	29.9x	Market cap / tangible book value, when positive.
P/FCF	9.42x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	8.12x	Market cap / cash from operations, when positive.
EV/Sales	0.23x	Enterprise value / revenue.
EV/EBITDA	38.8x	Enterprise value / EBITDA, when both are positive.
EV/FCF	8.20x	Enterprise value / free cash flow, when both are positive.
FCF yield	10.6%	Free cash flow / market cap.
Earnings yield	-0.9%	Net income / market cap (the inverse of P/E).
Dividend yield	5.0%	Dividends paid over the period / market cap.
Shareholder yield	5.2%	(Dividends paid + share buybacks) / market cap.

What was INSPERITY, INC.'s revenue in fiscal 2025?

INSPERITY, INC. reported revenue of $6.81B for fiscal 2025, 3.5% higher than the year before.

Was INSPERITY, INC. profitable in fiscal 2025?

No. It reported a net loss of $7.0M.

How much free cash flow did INSPERITY, INC. generate in fiscal 2025?

Cash from operations of $278.0M minus capital expenditures of $31.0M left free cash flow of -$309.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to INSPERITY, INC.